Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Oakes

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Scientific Reports|February 15, 2019
Ambient and controlled exposures to particulate air pollution and acute changes in heart rate variability and repolarizationSusanne Breitner, Annette Peters, Wojciech Zareba, et al.
Environmental Research|May 14, 2016
Does total antioxidant capacity modify adverse cardiac responses associated with ambient ultrafine, accumulation mode, and fine particles in patients undergoing cardiac rehabilitation?Meng Wang, Mark J Utell, Alexandra Schneider, et al.
Research Report (Health Effects Institute)|June 30, 2017
Ambient and Controlled Particle Exposures as Triggers for Acute ECG ChangesDavid Q Rich, Annette Peters, Alexandra Schneider, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 23, 2013
Caffeine consumption and risk of dyskinesia in CALM-PDAnne-Marie A Wills, Shirley Eberly, Marsha Tennis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's diseaseBernard Ravina, Kenneth Marek, Shirley Eberly, et al.
Archives of Neurology|February 16, 2006
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuationsKaren Blindauer, Ira Shoulson, David Oakes, et al.
Archives of Neurology|June 14, 2006
Preparing for preventive clinical trials: the Predict-HD studyJane S Paulsen, Michael Hayden, Julie C Stout, et al.
Clinical Parkinsonism & Related Disorders|December 4, 2023
Internal tremor in people with Parkinson's Disease: Demographic characteristics and comorbid symptomsLana M Chahine, Lakshmi Arbatti, Abhishek Hosamath, et al.
Nature Medicine|October 4, 2022
Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trialAndrew Feigin, Elizabeth E Evans, Terrence L Fisher, et al.
Nature Medicine|August 8, 2022
Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trialAndrew Feigin, Elizabeth E Evans, Terrence L Fisher, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Scientific Reports|February 15, 2019
Ambient and controlled exposures to particulate air pollution and acute changes in heart rate variability and repolarizationSusanne Breitner, Annette Peters, Wojciech Zareba, et al.
Environmental Research|May 14, 2016
Does total antioxidant capacity modify adverse cardiac responses associated with ambient ultrafine, accumulation mode, and fine particles in patients undergoing cardiac rehabilitation?Meng Wang, Mark J Utell, Alexandra Schneider, et al.
Research Report (Health Effects Institute)|June 30, 2017
Ambient and Controlled Particle Exposures as Triggers for Acute ECG ChangesDavid Q Rich, Annette Peters, Alexandra Schneider, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 23, 2013
Caffeine consumption and risk of dyskinesia in CALM-PDAnne-Marie A Wills, Shirley Eberly, Marsha Tennis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's diseaseBernard Ravina, Kenneth Marek, Shirley Eberly, et al.
Archives of Neurology|February 16, 2006
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuationsKaren Blindauer, Ira Shoulson, David Oakes, et al.
Archives of Neurology|June 14, 2006
Preparing for preventive clinical trials: the Predict-HD studyJane S Paulsen, Michael Hayden, Julie C Stout, et al.
Clinical Parkinsonism & Related Disorders|December 4, 2023
Internal tremor in people with Parkinson's Disease: Demographic characteristics and comorbid symptomsLana M Chahine, Lakshmi Arbatti, Abhishek Hosamath, et al.
Nature Medicine|October 4, 2022
Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trialAndrew Feigin, Elizabeth E Evans, Terrence L Fisher, et al.
Nature Medicine|August 8, 2022
Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trialAndrew Feigin, Elizabeth E Evans, Terrence L Fisher, et al.
Pageof 12